NasdaqCM - Nasdaq Real Time Price USD
GT Biopharma, Inc. (GTBP)
2.2300
+0.0500
+(2.29%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-12,904
-12,904
-8,852
-15,217
-15,606
Investing Cash Flow
12,893
12,893
-2,009
12,145
-23,040
Financing Cash Flow
2,976
2,976
6,268
-224
42,317
End Cash Position
4,044
4,044
1,079
5,672
8,968
Interest Paid Supplemental Data
--
--
213
--
--
Issuance of Capital Stock
2,976
2,976
6,268
--
24,679
Issuance of Debt
--
--
--
--
1,205
Repurchase of Capital Stock
--
--
--
-224
--
Free Cash Flow
-12,904
-12,904
-8,852
-15,217
-15,606
12/31/2021 - 3/27/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IPHA Innate Pharma S.A.
1.9955
+5.03%
IGC IGC Pharma, Inc.
0.2940
+2.80%
RGBPP Regen BioPharma, Inc.
0.0581
0.00%
LVTX LAVA Therapeutics N.V.
1.3600
-1.45%
SLXNW Silexion Therapeutics Corp
0.0650
-7.14%
VTVT vTv Therapeutics Inc.
20.55
+3.32%
1548.HK GENSCRIPT BIO
11.200
+1.45%
XTLB XTL Biopharmaceuticals Ltd.
1.2150
-7.25%
ANL Adlai Nortye Ltd.
2.0000
+9.29%
CALC CalciMedica, Inc.
1.5300
+0.66%